BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:14 PM
 | 
Sep 04, 2012
 |  BC Extra  |  Company News

Japanese panel backs approval of insulin degludec

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) said a Japanese drug advisory committee issued a positive recommendation on a...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >